Management of pain with comorbid substance abuse

Current Psychiatry Reports

Volumn 14, Issue 5, 2012, Pages 462-468

  Krashin, Daniel ^a   Murinova, Natalia ^a   Ballantyne, Jane ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Aberrant behavior; Acute pain; Addiction; Cancer pain; Chronic pain; Drug diversion; Opioid abuse; Opioid addiction; Opioid dependence; Opioid tolerance; Pain management; Palliative care; Psychological testing; Risk management; Risk stratification; Screening; Substance abuse; Substance abuse treatment; Urine drug screening

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHADONE; NARCOTIC ANALGESIC AGENT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BREAKTHROUGH PAIN; CANCER PATIENT; CHRONIC PAIN; CLINICAL PRACTICE; COMORBIDITY; DETOXIFICATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG MISUSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERANCE; FIBROMYALGIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; MENTAL STRESS; OPIATE ADDICTION; PAIN; PALLIATIVE THERAPY; PATIENT CONTROLLED ANALGESIA; PATIENT EDUCATION; PATIENT MONITORING; PRESCRIPTION; PSYCHOTHERAPY; PUBLIC HEALTH PROBLEM; REGIONAL ANESTHESIA; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SCREENING TEST; SOCIAL STATUS; TELECONSULTATION; TREATMENT PLANNING; URINALYSIS;

ACUTE DISEASE; ANALGESICS, OPIOID; CHRONIC DISEASE; COMORBIDITY; HUMANS; PAIN; PAIN MANAGEMENT; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTION DRUG MISUSE; SUBSTANCE-RELATED DISORDERS;

EID: 84870798239     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0298-3     Document Type: Article

References (53)

1. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235-55. (Pubitemid 46754581)
2. Administration SAMHS. Results from the 2010 National Survey on drug use and health: summary of national findings. MD: Rockville; 2011.
3. Morasco BJ, Gritzner S, Lewis L, et al. Systematic review of prevalence, correlates, and treatment outcomes for chronic noncancer pain in patients with comorbid substance use disorder. Pain. 2011;152:488-97.
4. Catalano RF, White HR, Fleming CB, Haggerty KP. Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 2011;36:79-86.
5. Cicero TJ, Surratt HL, Kurtz S, et al. Patterns of prescription opioid abuse and comorbidity in an aging treatment population. J Subst Abus Treat. 2012;42:87-94.
6. Ahlbeck K. Opioids. A two-faced Janus. Curr Med Res Opin. 2011;27:439-48.
7. Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87-95.
8. Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev. 2011;30:264-70.
9. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166-75.
10. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981-5.
11. Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325-8.
12. Green TC, Black R, Grimes Serrano JM, et al. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS One. 2011;6:e27244.
13. Kalant H. What neurobiology cannot tell us about addiction. Addiction. 2010;105:780-9.
14. O'Brien C. Addiction and dependence in DSM-V. Addiction. 2011;106:866-7.
15. Heit HA. Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. J Pain Palliat Care Pharmacother. 2003;17:15-29. (Pubitemid 36438352)
16. Jamison RN, Ross EL, Michna E, et al. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150:390-400.
17. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Off J Am Pain Soc: J Pain. 2009;10:113-30.
18. Younger JW, Chu LF, D'Arcy NT, et al. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152:1803-10.
19. Skurtveit S, Furu K, Borchgrevink P, et al. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain. 2011;152:1555-61.
20. Gentilello LM, Rivara FP, Donovan DM, et al. Alcohol interventions in a trauma center as a means of reducing the risk of injury recurrence. Ann Surg. 1999;230:473-80. discussion 480-473.
21. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212-27. (Pubitemid 38833284)
22. Neighbor ML, Dance TR, Hawk M, Kohn MA. Heightened pain perception in illicit substance-using patients in the ED: implications for management. Am J Emerg Med. 2011;29:50-6.
23. Barry DT, Goulet JL, Kerns RK, et al. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011;152:1133-8.
24. Edlund MJ, Martin BC, Fan MY, et al. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112:90-8.
25. Morasco BJ, Corson K, Turk DC, Dobscha SK. Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. J Pain. 2011;12:352-9.
26. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J Gen Intern Med. 2011;26:965-71.
27. Carroll CP, Haythornthwaite J. Maladaptive opioid use behaviors and psychiatric illness: what should we do with what we know? Curr Pain Headache Rep. 2011;15:91-3.
28. Goebel JR, Compton P, Zubkoff L, et al. Prescription sharing, alcohol use, and street drug use to manage pain among veterans. J Pain Symptom Manage. 2011;41:848-58.
29. Chan BK, Tam LK, Wat CY, et al. Opioids in chronic non-cancer pain. Expert Opin Pharmacother. 2011;12:705-20.
30. Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011;124:955-60.
31. Morasco BJ, Duckart JP, Carr TP, et al. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010;151:625-32.
32. Silverberg MJ, Ray GT, Saunders K, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28:39-46.
33. Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain. 2010;150:332-9.
34. Clark MR, Treisman GJ. Optimizing treatment with opioids and beyond. In: Clark MR, Treisman GJ, editors. Chronic Pain and Addiction. 2011. pp. 92-112.
35. Hwang SW, Wilkins E, Chambers C, et al. Chronic pain among homeless persons: characteristics, treatment, and barriers to management. BMC Fam Pract. 2011;12:73.
36. Heiwe S, Lonnquist I, Kallmen H. Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication. Eur J Pain. 2011;15:966-70.
37. Ilgen MA, Haas E, Czyz E, et al. Treating chronic pain in veterans presenting to an addictions treatment program. Cogn Behav Pract. 2011;18:149-60.
38. Manchikanti L, Singh V, Caraway DL, Benyamin RM. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse. Pain Physician. 2011;14:E103-17.
39. Simone CB, Vapiwala N, Hampshire MK, Metz JM. Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain. 2012;28:157-62.
40. Dev R, Parsons HA, Palla S, et al. Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer. 2011;117:4551-6.
41. Kircher S, Zacny J, Apfelbaum SM, et al. Understanding and treating opioid addiction in a patient with cancer pain. J Pain. 2011;12:1025-31.
42. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107-12. (Pubitemid 40590522)
43. Becker WC, Starrels JL, Heo M, et al. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011;9:219-25.
44. Vijayaraghavan M, Penko J, Guzman D, et al. Primary care providers' judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. J Gen Intern Med. 2011;26:412-8.
45. McGeary DD, McGeary CA, Gatchel RJ. A comprehensive review of telehealth for pain management: where we are and the way ahead. Pain Pract. 2012.
46. Meltzer EC, Rybin D, Saitz R, et al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011;152:397-402.
47. Moore T, Jones T, Browder J, et al. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009;10:1426-33.
48. Bohn TM, Levy LB, Celin S, et al. Screening for abuse risk in pain patients. In: Clark MR and Treisman GJ, editors. Chronic pain and addiction. 2011. pp. 113-24.
49. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097-102. (Pubitemid 37158696)
50. Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14:123-43.
51. Gupta A, Patton C, Diskina D, Cheatle M. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Pain Physician. 2011;14:383-9.
52. Starrels JL, Becker WC, Alford DP, et al. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712-20.
53. Jones JD, Sullivan MA, Manubay J, et al. The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. Neuropsychopharmacology. 2011;36:411-22.